The board of directors of a publicly-traded telecommunications services company engaged CRA to value the company’s intellectual property portfolio in the context of considering an offer to purchase the outstanding shares of the company. Findings and value conclusions from CRA’s report were included in the company’s SEC filings regarding the consideration of the offer.
Life Sciences Litigation Insights: April 2022
CRA’s Life Sciences Litigation team provides periodic summaries of notable developments in litigation. In this issue, we share notable cases from 2021 and...